Companies / Recursion Pharmaceuticals, Inc. / Activity
Activity — Recursion Pharmaceuticals, Inc.
44 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Borgeson Blake Director | Sell | Class A Common Stock | $959.2K | -220K -3.20% | 6,649,863 1.24% of shares | medium |
| Feb 3, 2026 | Borgeson Blake Director | Sell | Class A Common Stock | $924.0K | -220K -3.31% | 6,429,863 1.20% of shares | medium |
| Mar 3, 2026 | Borgeson Blake Director | Sell | Class A Common Stock | $588.2K | -170K -2.64% | 6,259,863 1.17% of shares | medium |
| Jan 20, 2026 | Gibson Christopher Director | Sell | Class A Common Stock | $178.8K | -40K -4.19% | 913,839 0.17% of shares | medium |
| Jan 5, 2026 | Gibson Christopher Director | Sell | Class A Common Stock | $170.0K | -40K -4.11% | 933,839 0.17% of shares | medium |
| Feb 4, 2026 | Gibson Christopher Director | Sell | Class A Common Stock | $164.8K | -40K -4.19% | 913,839 0.17% of shares | medium |
| Feb 19, 2026 | Gibson Christopher Director | Sell | Class A Common Stock | $138.4K | -40K -4.23% | 906,556 0.17% of shares | medium |
| Mar 23, 2026 | Gibson Christopher Director | Sell | Class A Common Stock | $130.0K | -40K -4.23% | 906,556 0.17% of shares | medium |
| Feb 17, 2026 | Gibson Christopher Director | Other | Class A Common Stock | $95.2K | -27K -2.92% | 906,556 0.17% of shares | low |
| Mar 9, 2026 | Khan Najat CEO | Sell | Class A Common Stock | $94.7K | -28K -1.24% | 2,262,085 0.42% of shares | low |
| Feb 17, 2026 | Khan Najat CEO | Other | Class A Common Stock | $49.8K | -14K -0.62% | 2,290,383 0.43% of shares | low |
| Feb 6, 2026 | Taylor Ben R Executive | Other | Class A Common Stock | $45.4K | -11K -0.93% | 1,220,683 0.23% of shares | low |
| Feb 6, 2026 | Hallett David Executive | Other | Class A Common Stock | $45.4K | -11K -1.02% | 1,109,059 0.21% of shares | low |
| Feb 17, 2026 | Taylor Ben R Executive | Other | Class A Common Stock | $41.6K | -12K -0.98% | 1,208,775 0.23% of shares | low |
| Feb 17, 2026 | Hallett David Executive | Other | Class A Common Stock | $41.6K | -12K -1.07% | 1,097,151 0.20% of shares | low |
| Feb 18, 2026 | Taylor Ben R Executive | Sell | Class A Common Stock | $41.4K | -13K -1.11% | 1,195,349 0.22% of shares | low |
| Feb 6, 2026 | Khan Najat CEO | Other | Class A Common Stock | $41.2K | -10K -0.45% | 2,304,663 0.43% of shares | low |
| Feb 6, 2026 | Gibson Christopher Director | Other | Class A Common Stock | $36.9K | -10K -1.10% | 933,821 0.17% of shares | low |
| Mar 17, 2026 | Taylor Ben R Executive | Sell | Class A Common Stock | $27.0K | -8K -0.67% | 1,180,318 0.22% of shares | low |
| Mar 16, 2026 | Taylor Ben R Executive | Other | Class A Common Stock | $24.2K | -7K -0.59% | 1,188,274 0.22% of shares | low |
| Jun 17, 2026 | Hershberg Robert Director | Grant | Class A Common Stock | $0 | +88K +119.93% | 162,156 0.03% of shares | low |
| Jan 2, 2026 | Li Dean Y Director | Grant | Class A Common Stock | $0 | +2K +0.19% | 1,240,909 0.23% of shares | low |
| Feb 6, 2026 | Taylor Ben R Executive | Grant | Class A Common Stock | $0 | +24K +2.01% | 1,232,083 0.23% of shares | low |
| Feb 6, 2026 | Taylor Ben R Executive | Grant | Class A Common Stock | $0 | +446K +58.60% | 1,207,829 0.23% of shares | low |
| Mar 23, 2026 | Gibson Christopher Director | Other | Class A Common Stock | $0 | +40K +4.41% | 946,556 0.18% of shares | low |
| Mar 9, 2026 | Gibson Christopher Director | Gift | Class A Common Stock | $0 | -20K -2.16% | 906,556 0.17% of shares | low |
| Mar 9, 2026 | Gibson Christopher Director | Other | Class A Common Stock | $0 | +20K +2.21% | 926,556 0.17% of shares | low |
| Feb 19, 2026 | Gibson Christopher Director | Other | Class A Common Stock | $0 | +40K +4.41% | 946,556 0.18% of shares | low |
| Feb 6, 2026 | Khan Najat CEO | Grant | Class A Common Stock | $0 | +30K +1.33% | 2,315,027 0.43% of shares | low |
| Feb 6, 2026 | Khan Najat CEO | Grant | Class A Common Stock | $0 | +1.7M +273.84% | 2,284,681 0.43% of shares | low |
| Feb 6, 2026 | Hallett David Executive | Grant | Class A Common Stock | $0 | +24K +2.21% | 1,120,459 0.21% of shares | low |
| Feb 6, 2026 | Hallett David Executive | Grant | Class A Common Stock | $0 | +502K +84.50% | 1,096,205 0.20% of shares | low |
| Feb 6, 2026 | Gibson Christopher Director | Grant | Class A Common Stock | $0 | +30K +3.32% | 944,185 0.18% of shares | low |
| Feb 4, 2026 | Gibson Christopher Director | Other | Class A Common Stock | $0 | +40K +4.38% | 953,839 0.18% of shares | low |
| Jan 20, 2026 | Gibson Christopher Director | Other | Class A Common Stock | $0 | +40K +4.38% | 953,839 0.18% of shares | low |
| Jan 5, 2026 | Gibson Christopher Director | Gift | Class A Common Stock | $0 | -20K -2.14% | 913,839 0.17% of shares | low |
| Jan 5, 2026 | Gibson Christopher Director | Other | Class A Common Stock | $0 | +60K +6.57% | 973,839 0.18% of shares | low |
| Jan 2, 2026 | Dar Zavain Director | Grant | Class A Common Stock | $0 | +4K +2.57% | 142,329 0.03% of shares | low |
| Mar 23, 2026 | Gibson Christopher Director | Other | Class B Common Stock | — | -40K -0.88% | 4,483,334 0.84% of shares | low |
| Mar 9, 2026 | Gibson Christopher Director | Other | Class B Common Stock | — | -20K -0.44% | 4,523,334 0.84% of shares | low |
| Feb 19, 2026 | Gibson Christopher Director | Other | Class B Common Stock | — | -40K -0.87% | 4,543,334 0.85% of shares | low |
| Feb 4, 2026 | Gibson Christopher Director | Other | Class B Common Stock | — | -40K -0.87% | 4,583,334 0.86% of shares | low |
| Jan 20, 2026 | Gibson Christopher Director | Other | Class B Common Stock | — | -40K -0.86% | 4,623,334 0.86% of shares | low |
| Jan 5, 2026 | Gibson Christopher Director | Other | Class B Common Stock | — | -60K -1.27% | 4,663,334 0.87% of shares | low |